Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 Protein
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400467 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Huihui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, China. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferase 1, Proteolysis, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Guangdong High-level New R&D Institute, Guangdong High-level Innovative Research Institute, Shanghai Science and Technology Development Funds.
Abstract (Originalsprache)
DNA methyltransferase 1 (DNMT1) is an attractive therapeutic target for acute myelocytic leukemia (AML) and other malignancies. It has been reported that the genetic depletion of DNMT1 inhibited AML cell proliferation through reversing DNA methylation abnormalities. However, no DNMT1‐targeted PROTAC degraders have been reported yet. Herein, a series of proteolysis‐targeting chimera (PROTAC) degrader of DNMT1 based on dicyanopyridine scaffold and VHL E3 ubiquitin ligase ligand was developed. Among them, KW0113 (DC 50 =643/899 nM in MV4–11/MOLM‐13 cells) exhibited optimal DNMT1 degradation. KW0113 induced DNMT1‐selective degradation in a dose‐ and time‐dependent manner through VHL engagement. Moreover, KW0113 inhibited AML cell growth by reversing promoter DNA hypermethylation and tumor‐suppressor genes silencing. In conclusion, these findings proved the capability of PROTAC strategy for inducing DNMT1 degradation, demonstrated the therapeutic potential of DNMT1‐targeted PROTACs. This work also provided a convenient chemical knockdown tool for DNMT1‐related studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
- State Key Laboratory of Respiratory Disease, China-New Zealand Joint Laboratory on Biomedicine and Health, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine…
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
ORCID-Profile: Mingliang Wang
Förderung
- Guangdong High-level New R&D Institute
- Guangdong High-level Innovative Research Institute
- Shanghai Science and Technology Development Funds
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Pearl River Talents Plan
- Open Project of State Key Laboratory of Respiratory Disease
Zitieren
APA
Wang, H., Wang, Z., Hu, L., Yang, B., Zong, L., Xu, D., Yu, B., Kong, X., & Wang, M. (2024). Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 Protein. ChemMedChem. https://doi.org/10.1002/cmdc.202400467
Vancouver
Wang H, Wang Z, Hu L, Yang B, Zong L, Xu D, et al. Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 Protein. ChemMedChem. 2024. doi:10.1002/cmdc.202400467
BibTeX
@article{Wang2024,
author = {Wang, Huihui and Wang, Zhaoliang and Hu, Linghao and Yang, Bingjie and Zong, Liangyi and Xu, Dounan and Yu, Bo and Kong, Xiangqian and Wang, Mingliang},
title = {Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 Protein},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400467}
}
EUVIMED